Cerulea Clinical Trials

Cerulea Clinical Trials Cerulea Clinical Trials is a specialist ophthalmology clinical trial site and contract research organisation.

We're a not-for-profit subsidiary of the Centre for Eye Research Australia and dedicated to excellence in clinical research. Cerulea Clinical Trials delivers ophthalmic clinical trials for Australian and international biopharmaceutical and medtech companies – and is the home of investigator-initiated studies for the Centre for Eye Research Australia (CERA). We are a fully owned, not-for-profit subsidiary of CERA and share its vision of a world free from vision loss and blindness.

✨ This Orthoptics Awareness Week, we’re highlighting the important role orthoptists play in advancing eye care and resea...
05/06/2026

✨ This Orthoptics Awareness Week, we’re highlighting the important role orthoptists play in advancing eye care and research. We spoke with Cerulea Clinical Trials Coordinator, Regina Callegher, about her journey and how orthoptists contribute to clinical trials and better outcomes for people living with eye disease.

➡️ How do you support clinical trials?

I work across a range of clinical trials investigating treatments for various eye conditions. I utilise my orthoptic skills as a visual acuity examiner and perform ophthalmic imaging for participants enrolled in studies evaluating new treatments for conditions such as diabetic macular oedema, wet age-related macular degeneration (AMD), thyroid eye disease and geographic atrophy (dry AMD).

As a coordinator, I manage studies in thyroid eye disease and intermediate AMD. This involves recruiting and screening potential participants, ensuring trial protocols and visit schedules are followed, maintaining regulatory and ethics documentation, and supporting participants throughout their involvement.

➡️ What inspired you to become an orthoptist?

I have strabismus (an eye turn) and, as a child, was under the care of both an orthoptist and an ophthalmologist. These positive experiences, combined with a strong interest in biology and health sciences at school, inspired me to pursue orthoptics as a career.

➡️ How did you move into clinical research?

I first worked as an orthoptist in private practice and low vision services. I later decided to broaden my career by transitioning into clinical research and joined Cerulea (formerly CERA) five years ago. This role has allowed me to combine my clinical expertise with a passion for advancing new treatments and improving patient outcomes.

➡️ What skills do orthoptists bring to clinical trial teams?

Orthoptists bring a unique combination of clinical expertise and patient-centred care. We are skilled in performing visual acuity assessments, slit-lamp examinations and ophthalmic imaging, as well as assisting with procedures such as angiograms and intravitreal injections.

Our in-depth understanding of the visual system also enables us to educate participants about their eye conditions, treatment options and available care pathways.

In a research setting, these skills help ensure high-quality data collection while providing participants with confidence and support throughout their trial experience.

➡️ What do you find most rewarding about working in clinical trials?

The opportunity to build meaningful relationships with participants and supporting them throughout their research journey – while contributing to the development of potential new treatments.

It’s incredibly fulfilling to know the work we do today may help improve outcomes for people living with eye conditions in the future and contribute to advancing the standard of care. Being part of research with the potential to benefit future generations is something I find both motivating and rewarding.

Today marks not only International Clinical Trials Day, but also two years of Cerulea Clinical Trials.To celebrate, we b...
20/05/2026

Today marks not only International Clinical Trials Day, but also two years of Cerulea Clinical Trials.

To celebrate, we brought together ophthalmologists, study coordinators and clinical trial participants to mark this milestone.

Our CEO, Dr Michelle Bradney, and Chief Medical Officer, Professor Lyndell Lim, shared their perspectives on the role of clinical trials. Study participant Tom Valenta also spoke about his experience and why clinical trials are so important.

We were pleased to welcome many new visitors to tour our facilities, gaining first-hand insight into how clinical trials are conducted and meeting the brilliant team at Cerulea, who are helping bring the biggest breakthroughs in research to patients as quickly as possible.

Thank you to everyone who joined us for a behind-the-scenes look – and to everyone who made the day a success.



Photo 1 (L-R): Dr Bradney, Prof Lim, Tom Valenta, Clinical Research Coordinator Marinel Tuazon and Brett Mitsch, CIO of Breakthrough Victoria

🗓️ In just two weeks, we're celebrating our 2nd birthday on World Clinical Trials Day – and you’re invited to a special ...
06/05/2026

🗓️ In just two weeks, we're celebrating our 2nd birthday on World Clinical Trials Day – and you’re invited to a special behind-the-scenes look at Cerulea Clinical Trials.

Whether you’ve considered taking part in an ophthalmic study or you’re an eyecare professional wanting an inside perspective of how trials work, this free event is ideal for you.

There will be a panel discussion with clinical trial leaders, clinicians, study coordinators and participants – plus guided tours of our state-of-the-art facility.

🏥 Where: Level 7, The Royal Victorian Eye and Ear Hospital
🕛 When: Wednesday 20 May, 12:00–2:30pm
☕ Light refreshments provided.

Book now via the link in the comments to secure your place ⬇️

For many people diagnosed with serious and complex eye conditions, “nothing can be done” was once the distressing respon...
30/04/2026

For many people diagnosed with serious and complex eye conditions, “nothing can be done” was once the distressing response they heard.

Two years since opening, Cerulea Clinical Trials has been delivering Phase I–IV clinical trials across a range of eye diseases, working in areas where treatment options have been limited or, in some cases, did not previously exist.

During this time, Cerulea has supported trials for conditions including retinitis pigmentosa, uveitis, glaucoma, age‑related macular degeneration and rare inherited eye diseases – in close partnership with biotechnology and pharmaceutical companies – and alongside the people who stand to benefit from new treatments.

Continue reading as CEO Dr Michelle Bradney and Chief Medical Officer Professor Lyndell Lim reflect on Cerulea's two years of working to bring transformative treatments to Victorians (link in comments) ⬇️

We’re turning two - and you’re invited!To celebrate our second birthday and International Clinical Trials Day, join us f...
20/04/2026

We’re turning two - and you’re invited!

To celebrate our second birthday and International Clinical Trials Day, join us for a behind-the-scenes look at how ophthalmic clinical trials really work and what it’s like to take part in eye research.

This free event is ideal for:
- Anyone who has ever considered joining an ophthalmic clinical research study
- Eyecare professionals interested in understanding clinical trials and the participant experience.

There will be a panel discussion with clinicians, study coordinators and trial participants, as well as guided tours of our state-of-the-art facility.

Where: Level 7, The Royal Victorian Eye and Ear Hospital
When: Wednesday 20 May, 12:00–2:30pm
Light refreshments provided.

Tickets are free, but registrations are essential.

Register here: https://events.humanitix.com/cerulea-clinical-trials-tour

👁️‍🗨️📻 The Hope in Sight audio library series features the voices and stories of people who've been involved in research...
23/02/2026

👁️‍🗨️📻 The Hope in Sight audio library series features the voices and stories of people who've been involved in research at Cerulea Clinical Trials and the Centre for Eye Research Australia.

In epsisode 1, Trish, a New Zealander living in Australia with Usher syndrome, shares her journey from initial diagnosis to participating in medical research.

Trish was initially reluctant to participate in medical research due to her past experiences, but her involvement in clinical trials has provided her with a sense of control and hope.

LIsten to Trish talk about her supportive community, and the positive impact of research on her life and broader Usher syndrome community (link in comments).

Pictured: A clinical trial coordinator scans the eyes of a participant.

✨ As 2025 draws to a close, we want to extend our heartfelt thanks to our partners, sponsors, investigators and incredib...
24/12/2025

✨ As 2025 draws to a close, we want to extend our heartfelt thanks to our partners, sponsors, investigators and incredible trial participants who have made this year a success. Together, we're continuing to advance ophthalmic research and bringing hope closer to people living with vision loss. ✨

From everyone at Cerulea Clinical Trials, we wish you and your loved ones a happy festive season! Here's to an exciting new year with groundbreaking trials, new partnerships and continued progress in eye care.

Our office will be closed from today, 24 December, and will reopen on Monday, 5 January. We look forward to continuing our important work together in 2026!

Pictured: Members of the Cerulea team standing together at the 2025 Vision Expo.

03/12/2025

According to Vision Australia, around 18% of Australian adults experience print disability. Difficulty reading and understanding print can be associated with impacts to vision, learning and physical abilities. Accessible information is important and offering information in different formats to meet differing needs is the goal at CERA and Cerulea Clinical Trials.

The Hope in Sight audio library series has been developed by CERA Consumer Advisory Lead Fleur O’Hare and Knowable Me Managing Director Kelly Schulz to help prepare people for what's it's like to participate in a clinical trial.

This International Day of People with Disability, visit our consumer resources page to hear from eight individuals about their journey with research and hope for the future: https://ow.ly/LFVG50XB56K

Pictured: Clinical trials volunteer Tom Valenta OAM and Dr Flora Hui, CERA Research Fellow

At Cerulea, we’re running clinical trials with the aim of bringing safe and effective treatments to people living with e...
29/10/2025

At Cerulea, we’re running clinical trials with the aim of bringing safe and effective treatments to people living with eye disease, thanks to the amazing support of our clinical trial participants. ✨

We’re dedicated to providing them with the best possible trial experience at our state-of-the-art ophthalmic trial suites on Level 7 (Blue Wing) of The Royal Victorian Eye and Ear Hospital.

When participants step out of the lifts into our modern and relaxing lounge area, they're welcomed by Clinical Trial Assistant Rebecca who loves being the first point of contact.

“I believe great customer service is about empathy, connection and making every person feel heard. There is no greater feeling then witnessing participants feeling at home when visiting Cerulea."

If you’re interested in taking part in clinical trials at Cerulea, and would like to know more, please visit our website: https://ow.ly/3bvg50XiUbY

🌟 We’re delighted to announce that senior pharmaceutical and biotechnology executive Dr Michelle Bradney has been appoin...
06/10/2025

🌟 We’re delighted to announce that senior pharmaceutical and biotechnology executive Dr Michelle Bradney has been appointed as the new Chief Executive Officer of Cerulea Clinical Trials.

Dr Bradney begins her role on 20 October and brings more than two decades of experience in medical affairs and clinical development across global pharmaceutical companies and ASX-listed biotechnology firms.

She joins Cerulea from OccuRx, where she served as Chief Operating Officer, and has extensive ophthalmic clinical trials experience through senior roles at Allergan, where she led clinical monitoring operations.

Dr Bradney also holds governance roles in the life sciences sector, including as a board observer with Medicines Australia and a member of the Women on Boards Naomi Simson syndicate.

Dr Bradney brings a wealth of experience in navigating complex regulatory environments and managing high-stakes clinical trial operations to Cerulea.

We look forward to working with Dr Bradney to expand the number of trials delivered, attract new industry-sponsored ophthalmic studies to Australia and establish Cerulea as a global hub for ophthalmic clinical trials.

We’d also like to extend a special thank you to Dr Adele Hosseini, who has served as Interim CEO since May 2025.

Her outstanding leadership has laid a strong foundation for the future growth and success of Cerulea.

Please join us in congratulating Dr Bradney on her appointment! 🎉

Address

Level 7, The Royal Victorian Eye And Ear Hospital, 32 Gisbourne Street
Melbourne, VIC
3002

Alerts

Be the first to know and let us send you an email when Cerulea Clinical Trials posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Cerulea Clinical Trials:

Featured

Share